Mesenchymal Stem (Stromal) Cells for Treatment of ARDS: A Phase 1 Clinical Trial

BACKGROUND: There is no effective pharmacotherapy for the acute respiratory distress syndrome (ARDS), and mortality remains high. Preclinical studies support the efficacy of mesenchymal stem (stromal) cells (MSCs) in the treatment of lung injury. The aim of this phase one clinical trial was to test...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Lancet Respir Med
Hlavní autoři: Wilson, Jennifer G., Liu, Kathleen D., Zhuo, Hanjing, Caballero, Lizette, McMillan, Melanie, Fang, Xiaohui, Cosgrove, Katherine, Vojnik, Rosemary, Calfee, Carolyn S., Lee, Jae-Woo, Rogers, Angela J., Levitt, Joseph, Wiener-Kronish, Jeanine, Bajwa, Ednan K., Leavitt, Andrew, McKenna, David, Thompson, B. Taylor, Matthay, Michael A.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2014
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4297579/
https://ncbi.nlm.nih.gov/pubmed/25529339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-2600(14)70291-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky